Effect of nerve blocks of different approaches on the analgesic efficacy after arthroscopic shoulder surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400088253

Enrollment

Unknown

Registered

2024-08-14

Start date

2024-09-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff injury

Interventions

one:Liposomal bupivacaine 133mg was injected into the posterior suprascapular nerve and the posterior axillary nerve

two:Liposomal bupivacaine 133mg was injected into the posterior suprascapular nerve and the anterior axillary nerve

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing arthroscopic rotator cuff repair in the First Affiliated Hospital of Zhengzhou University; (2) ASA?-?; (3) Age =18, =65 years old, gender is not limited; (4) BMI: 18-30kg/m2; (5) Patients were treated with nerve block and PCIA after operation.

Exclusion criteria

Exclusion criteria: (1) Accompanied by nerve injury or diseases around the shoulder joint, including thoracic outlet syndrome, multiple sclerosis, cervical intervertebral disc disease with ipsilateral radiculopathy, etc. (2) Accompanied by abnormal sensory or motor function of upper limbs; (3) There is active infection at the puncture site, or there is coagulation dysfunction (hemophilia, von Willebrand, or international normalized ratio INR > 2); (4) Severe respiratory diseases and a history of serious cardiovascular and cerebrovascular diseases; (5) Combined with diabetes or nervous system dysfunction; (6) Unable to understand or cooperate with VAS raters; (7) History of shoulder surgery; (8) Failed nerve block; (9) History of local anesthetic allergy in the past; (10) Long-term use of opioids (use time =3 months or use time =1 month and daily dose =5mg morphine equivalent); (11) Operation time 3h.

Design outcomes

Primary

Measure	Time frame
Area under the curve (AUC) of rest pain intensity scores through 72 hours postsurgery ;	—

Secondary

Measure	Time frame
Pain intensity scores;Time to first postsurgical opioid rescue medication;Postsurgical opioid consumption;Motor function of upper limbs;Sensory function of upper limbs;Diaphragmatic excursion;Spirometry;Satisfaction degree of analgesic treatment;Sleep quality;	—

Countries

China

Contacts

Public ContactXue Qiong

The First Affiliated Hospital of Zhengzhou University

fccxueq@zzu.edu.cn+86 138 3716 0267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026